Breast Cancer Stem Cells Survive Periods of Farnesyl-Transferase Inhibitor-Induced Dormancy by Undergoing Autophagy
Figure 1
Immunofluorescence of markers associated with breast cancer stem cells. MCF-7 were treated with 25 M FTI for 72 h, fixed with paraformaldehyde, and incubated with antibodies specific for CD44 or ALDH1. Shown is a comparison of dormant and growing MCF-7 cells.
